These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition. Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163 [TBL] [Abstract][Full Text] [Related]
4. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Feltkamp MC; Smits HL; Vierboom MP; Minnaar RP; de Jongh BM; Drijfhout JW; ter Schegget J; Melief CJ; Kast WM Eur J Immunol; 1993 Sep; 23(9):2242-9. PubMed ID: 7690326 [TBL] [Abstract][Full Text] [Related]
5. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. Sijts AJ; Ossendorp F; Mengedé EA; van den Elsen PJ; Melief CJ J Immunol; 1994 Jan; 152(1):106-16. PubMed ID: 8254184 [TBL] [Abstract][Full Text] [Related]
6. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones. Deckhut AM; Tevethia SS J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447 [TBL] [Abstract][Full Text] [Related]
7. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen. Kuhröber A; Schirmbeck R; Reimann J Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132 [TBL] [Abstract][Full Text] [Related]
8. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. Ressing ME; Sette A; Brandt RM; Ruppert J; Wentworth PA; Hartman M; Oseroff C; Grey HM; Melief CJ; Kast WM J Immunol; 1995 Jun; 154(11):5934-43. PubMed ID: 7538538 [TBL] [Abstract][Full Text] [Related]
9. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. Lipford GB; Hoffman M; Wagner H; Heeg K J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422 [TBL] [Abstract][Full Text] [Related]
10. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Bonneau RH; Salvucci LA; Johnson DC; Tevethia SS Virology; 1993 Jul; 195(1):62-70. PubMed ID: 7686314 [TBL] [Abstract][Full Text] [Related]
11. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein. Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508 [TBL] [Abstract][Full Text] [Related]
13. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. Hudrisier D; Oldstone MB; Gairin JE Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947 [TBL] [Abstract][Full Text] [Related]
14. A molecular basis for how a single TCR interfaces multiple ligands. Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402 [TBL] [Abstract][Full Text] [Related]
15. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides. Martin S; Ortmann B; Pflugfelder U; Birsner U; Weltzien HU J Immunol; 1992 Oct; 149(8):2569-75. PubMed ID: 1383319 [TBL] [Abstract][Full Text] [Related]
16. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Doan T; Chambers M; Street M; Fernando GJ; Herd K; Lambert P; Tindle R Virology; 1998 May; 244(2):352-64. PubMed ID: 9601506 [TBL] [Abstract][Full Text] [Related]
17. MUC1 peptide epitopes associated with five different H-2 class I molecules. Apostolopoulos V; Haurum JS; McKenzie IF Eur J Immunol; 1997 Oct; 27(10):2579-87. PubMed ID: 9368613 [TBL] [Abstract][Full Text] [Related]
18. Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein. Schoel B; Zügel U; Ruppert T; Kaufmann SH Eur J Immunol; 1994 Dec; 24(12):3161-9. PubMed ID: 7805744 [TBL] [Abstract][Full Text] [Related]
19. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule. Romero P; Eberl G; Casanova JL; Cordey AS; Widmann C; Luescher IF; Corradin G; Maryanski JL J Immunol; 1992 Mar; 148(6):1871-8. PubMed ID: 1541825 [TBL] [Abstract][Full Text] [Related]
20. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties. Bristol JA; Schlom J; Abrams SI J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]